V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20167759 | 20088020 | 1.74 | 60 | null | 2018-05-12 | 2018-06-11 | EEF or EOF | 01 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101035878 |
| 20167950 | 20088021 | 0 | 0 | Palliative (P) | 2021-07-23 | 2021-08-04 | CARBOPLATIN + VINORELBINE | 01 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100942228 |
| 20168492 | 20088022 | 1.63 | 71.6 | Adjuvant (A) | 2017-08-21 | 2017-09-07 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101547758 |
| 20168615 | 20088023 | 1.57 | 76 | Palliative (P) | 2017-02-28 | 2017-03-20 | CAP + RT | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101279647 |
| 20168812 | 20088024 | 1.51 | null | Adjuvant (A) | 2018-04-29 | 2018-05-06 | Letrozole + Palbociclib | 02 | N | OBINUTUZUMAB | 100473143 |
| 20169007 | 20088025 | null | 89.7 | null | 2019-01-18 | 2019-01-18 | Olaparib | N | N | PACLITAXEL + TRASTUZUMAB | 100987130 |
| 20169080 | 20088027 | 1.72 | 53 | 03 | 2018-08-16 | 2018-08-18 | ACTICCA-1 Trial | 02 | N | DOXORUBICIN | 101573318 |
| 20169092 | 20088028 | 1.7 | 84.8 | null | 2017-12-17 | 2017-12-24 | NEO-AEGIS TRIAL | 02 | N | BENDAMUSTINE + RITUXIMAB | 100274021 |
| 20169180 | 20088030 | 1.72 | 103.6 | Palliative (P) | 2017-11-25 | 2017-11-26 | ACELARATE Trial | 02 | Y | LENALIDOMIDE | 100813839 |
| 20169372 | 20088031 | null | null | Palliative (P) | 2019-09-24 | 2019-09-24 | COSMIC TRIAL | 01 | N | ARISTOTLE TRIAL | 101096059 |
| 20169414 | 20088032 | 1.62 | 61.3 | Adjuvant (A) | null | 2016-12-17 | ACELARATE Trial | 02 | N | EVEROLIMUS | 100394032 |
| 20169417 | 20088033 | 1.73 | 92 | Palliative (P) | 2019-07-31 | 2019-08-15 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 99 | Y | DOXORUBICIN | 100075285 |
| 20169607 | 20088034 | 1.82 | 72.1 | null | 2017-09-21 | 2017-09-21 | Carboplatin + Vinorelbine IV | 02 | N | PACLITAXEL | 100006804 |
| 20169683 | 20088035 | 0 | 8.7 | null | 2017-11-08 | 2017-11-16 | Capecitabine + Streptozocin | N | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100250789 |
| 20169696 | 20088036 | null | 74.2 | 03 | 2018-02-01 | 2018-03-07 | ACELARATE Trial | 01 | Y | DOXORUBICIN + OLARATUMAB | 100525180 |
| 20169917 | 20088037 | 1.59 | 63 | Palliative (P) | 2018-03-21 | 2018-04-04 | Docetaxel 100mg/m2 (21 day) | 02 | N | PANITUMUMAB | 101070390 |
| 20170038 | 20088038 | 1.78 | 79.2 | Palliative (P) | 2019-09-25 | 2019-09-30 | ACTICCA-1 Trial | N | N | DABRAFENIB + TRAMETINIB | 100730681 |
| 20170103 | 20088040 | 1.54 | null | Palliative (P) | 2018-01-20 | 2018-02-08 | Panitumumab | 02 | N | FLUOROURACIL + RT | 100156618 |
| 20170124 | 20088041 | 1.55 | 85.5 | Palliative (P) | 2019-05-05 | 2019-05-25 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 101174376 |
| 20170144 | 20088042 | 1.9 | 78.9 | Palliative (P) | 2016-06-18 | 2016-07-05 | ARISTOTLE TRIAL | 02 | N | ARISTOTLE TRIAL | 100538212 |
| 20170223 | 20088043 | 0 | 0 | Adjuvant (A) | 2019-10-04 | 2019-10-11 | CHOP R - 21 days | 02 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100854169 |
| 20170452 | 20088044 | null | null | 03 | null | 2020-03-02 | MCX | 2 | N | IRINOTECAN | 100554366 |
| 20170649 | 20088045 | 1.67 | 45 | Palliative (P) | 2020-11-29 | 2020-12-12 | Panitumumab | 02 | N | LIPOSOMAL DAUNORUBICIN + LIPOSOMAL CYTARABINE (VYXEOS) | 100399757 |
| 20170818 | 20088047 | null | null | Palliative (P) | 2018-12-28 | 2019-01-03 | OXALIPLATIN + MDG + PANITUMUMAB | 01 | Y | NAB-PACLITAXEL | 100531977 |
| 20170931 | 20088048 | 1.7 | 88.6 | Neo-adjuvant (N) | 2019-12-25 | 2019-12-29 | ESPAC-4 TRIAL | 2 | N | IRINOTECAN + MDG + PANITUMUMAB | 101210592 |
| 20171067 | 20088049 | 1.62 | 63.2 | null | 2019-12-08 | 2019-12-09 | null | 02 | N | PEMBROLIZUMAB | 101456253 |
| 20171172 | 20088051 | 1.57 | 81.2 | null | 2019-06-11 | 2019-07-08 | Pertuzumab (Loading) | 02 | N | ARISTOTLE TRIAL | 101082829 |
| 20171250 | 20088052 | 1.17 | 55.6 | null | 2016-09-30 | 2016-10-06 | ECarboX | 02 | null | DOXORUBICIN | 101195363 |
| 20171289 | 20088053 | 1.73 | 102.5 | Palliative (P) | 2017-08-22 | 2017-08-24 | Abiraterone | 02 | N | FOXFIRE TRIAL | 100369528 |
| 20171355 | 20088054 | null | 103 | 03 | 2018-03-07 | 2018-03-07 | Hydroxycarbamide | 02 | N | ABC-08 TRIAL | 100547999 |
| 20171436 | 20088055 | 1.73 | 90 | 03 | null | 2020-01-08 | ACELARATE Trial | 01 | N | EVEROLIMUS | 101200005 |
| 20171611 | 20088056 | 1.66 | 68.5 | Palliative (P) | 2017-04-04 | 2017-04-04 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | ECARBOX | 100691231 |
| 20171685 | 20088057 | 1.62 | 98 | Neo-adjuvant (N) | 2017-12-04 | 2017-12-28 | Cladribine (subcut) 5 days | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100753451 |
| 20171703 | 20088059 | 1.83 | 76.2 | 03 | 2017-09-25 | 2017-09-28 | BENDAMUSTINE + RITUXIMAB | 02 | N | CARBOPLATIN + FLUOROURACIL | 100611450 |
| 20171755 | 20088060 | 1.6 | 62 | 03 | 2019-12-04 | 2019-12-10 | ACTICCA-1 Trial | 02 | N | PACLITAXEL | 101700585 |
| 20171944 | 20088061 | 1.62 | 44.9 | null | 2019-01-31 | 2019-01-31 | SCOPE 2 TRIAL | 02 | N | NEO-AEGIS TRIAL | 101207487 |
| 20172079 | 20088062 | null | 83 | 03 | 2016-09-19 | 2016-10-02 | Abiraterone | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100490910 |
| 20172280 | 20088063 | 1.69 | 81.6 | Palliative (P) | 2022-04-05 | 2022-05-27 | GEMCARBO | null | N | CAPECITABINE + STREPTOZOCIN | 100361876 |
| 20172335 | 20088064 | 1.68 | 93.7 | Neo-adjuvant (N) | 2018-12-23 | 2018-12-23 | Rituximab | 01 | N | AZACITIDINE | 101193831 |
| 20172650 | 20088065 | 1.6 | 65.6 | null | 2017-09-27 | 2017-09-27 | PEMBROLIZUMAB | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100315898 |
| 20172794 | 20088066 | 1.7 | 59.85 | Palliative (P) | 2019-07-26 | 2019-08-07 | Chlorambucil | N | N | CHOP R | 100957617 |
| 20172887 | 20088067 | 1.61 | 110.2 | 03 | 2020-03-21 | 2020-04-04 | IBRUTINIB | N | Y | ECARBOX | 101667430 |
| 20172987 | 20088068 | 1.62 | 88.55 | Palliative (P) | 2019-07-24 | 2019-07-28 | CARBOPLATIN + FLUOROURACIL | 01 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100488470 |
| 20173337 | 20088069 | 1.84 | 62.4 | 03 | 2016-10-11 | 2016-10-14 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100025739 |
| 20173395 | 20088070 | 1.66 | 50.4 | 03 | 2019-02-26 | 2019-02-27 | EOF | 02 | N | PAZOPANIB | 100755881 |
| 20173661 | 20088072 | 1.61 | 66.4 | null | 2019-07-30 | 2019-08-12 | null | 02 | N | AML19 TRIAL | 100515364 |
| 20173716 | 20088073 | 1.71 | 66.7 | Adjuvant (A) | 2019-06-08 | 2019-06-22 | CHOP - 21 days | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100290008 |
| 20173772 | 20088074 | null | 54.6 | Adjuvant (A) | 2020-02-12 | 2020-03-03 | Hydroxycarbamide | 02 | N | PEMBROLIZUMAB | 100164396 |
| 20173939 | 20088075 | 1.54 | 77 | Palliative (P) | 2018-05-14 | 2018-05-22 | DOXORUBICIN | 02 | N | AZACITIDINE | 101403820 |
| 20174021 | 20088076 | 1.8 | 86 | Neo-adjuvant (N) | 2017-11-29 | 2017-12-18 | FEC 100 | 02 | N | OXALIPLATIN | 101246730 |